CAMM Investigators in collaboration with the Rapid Research in Diagnostics Development for TB (R2D2) Network launch The Candidate Clinical Correlate as Prognostic Outcome for TB (C3PO) Trial. C3PO seeks to evaluate predictors of serious post-treatment outcomes among TB survivors, including recurrent TB and lung dysfunction.
